Morgan Stanley’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
|
|||||
|
2025
Q1 | $70.3K | Sell |
|
|||||
|
2024
Q4 | $377K | Buy |
|
|||||
|
2024
Q3 | $132K | Buy |
|
|||||
|
2024
Q2 | $83.2K | Sell |
|
|||||
|
2024
Q1 | $934K | Sell |
|
|||||
|
2023
Q4 | $1.84M | Buy |
|
|||||
|
2023
Q3 | $3.28M | Sell |
|
|||||
|
2023
Q2 | $4.03M | Sell |
|
|||||
|
2023
Q1 | $8.55M | Buy |
|
|||||
|
2022
Q4 | $8.82M | Sell |
|
|||||
|
2022
Q3 | $11.1M | Sell |
|
|||||
|
2022
Q2 | $25.1M | Buy |
|
|||||
|
2022
Q1 | $28.2M | Buy |
|
|||||
|
2021
Q4 | $40.1M | Sell |
|
|||||
|
2021
Q3 | $50.3M | Sell |
|
|||||
|
2021
Q2 | $47.2M | Sell |
|
|||||
|
2021
Q1 | $45.7M | Sell |
|
|||||
|
2020
Q4 | $71.2M | Buy |
|
|||||
|
2020
Q3 | $17M | Buy |
|
|||||
|
2020
Q2 | $11.3M | Sell |
|
|||||
|
2020
Q1 | $29.5M | Buy |
|
|||||
|
2019
Q4 | $48.3M | Sell |
|
|||||
|
2019
Q3 | $41.7M | Buy |
|
|||||
|
2019
Q2 | $40.2M | Buy |
|
|||||
|
2019
Q1 | $51M | Sell |
|
|||||
|
2018
Q4 | $63.6M | Sell |
|
|||||
|
2018
Q3 | $78.2M | Sell |
|
|||||
|
2018
Q2 | $75M | Sell |
|
|||||
|
2018
Q1 | $84.2M | Buy |
|
|||||
|
2017
Q4 | $31.4M | Buy |
|
|||||
|
2017
Q3 | $23.8M | Buy |
|
|||||
|
2017
Q2 | $13.8M | Buy |
|
|||||
|
2017
Q1 | $3.6M | Buy |
|
|||||
|
2016
Q4 | $1M | Buy |
|
|||||
|
2016
Q3 | $164K | Buy |
|
|||||
|
2016
Q2 | $85K | Sell |
|
|||||
|
2016
Q1 | $112K | Sell |
|
|||||
|
2015
Q4 | $3.33M | Buy |
|
|||||
|
2015
Q3 | $608K | Buy |
|
|||||
|
2015
Q2 | $318K | Buy |
|
|||||
|
2015
Q1 | $4K | Sell |
|
|||||
|
2014
Q4 | $20K | Buy |
|